Delivery Order SPE2DB20D3101-SPE2DB25FRGE7
Award Date
4/8/25
Potential Completion Date
4/29/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,688.23, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific socioeconomic program. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,688.23 delivery order contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $4,917.64 and is for the delivery of the specialty pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 2, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products. This is a Firm Fixed Price delivery order contract that does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of April 30, 2025. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,458.82, is a delivery order for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has a firm fixed price and an ultimate completion date of January 29, 2025. The award is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,229.41, is a Firm Fixed Price Delivery Order for the medical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 3, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,458.82, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed price delivery order. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,917.64, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of February 13, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a significant...